Đang chuẩn bị liên kết để tải về tài liệu:
Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: Results from a clinical series
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Stage shift is widely considered a major determinant of the survival benefit conferred by breast cancer screening. However, factors and mechanisms underlying such a prognostic advantage need further clarification. We sought to compare the molecular characteristics of screen detected vs. symptomatic breast cancers and assess whether differences in tumour biology might translate into survival benefit. |